Watch IXHL. Know when insiders buy.
One email the day a filing lands. Free.
IXHL
Incannex Healthcare Inc.
2.76
+0.02 +0.55%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
76
PASS · shorts 76
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $33MP/E 0.1DIV YIELD —FCF YIELD -53.70%REV TTM —NET INCOME −$48.4MNET CASH $72.1M52W 2.56 – 14.37SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2026 · Mar 31 | — | — | — | −$4M | −$3.9M | — | -0.35 | −$2.5M | $5K | −$2.5M | May 15 |
| Q2 2026 · Dec 31 | — | — | — | −$7M | −$6.5M | — | -0.02 | −$4.6M | $4K | −$4.6M | May 15 |
| Q1 2026 · Sep 30 | — | — | — | −$6.8M | −$6.4M | — | -0.02 | −$9.2M | $2K | −$9.2M | May 15 |
| Q4 2025 · Jun 30derived | — | — | — | −$7.5M | −$31.6M | — | 24.04 | −$1.5M | $0 | −$1.5M | Sep 29 |
| Q3 2025 · Mar 31 | $0 | — | — | −$5M | −$4M | — | -6.19 | −$3.2M | $0 | −$3.2M | May 15 |
| Q2 2025 · Dec 31 | $12K | — | — | −$5M | −$5.9M | — | -0.33 | −$5.6M | — | — | May 15 |
| Q1 2025 · Sep 30 | $74K | — | — | −$6.3M | −$5.4M | — | -0.29 | −$2.2M | — | — | May 15 |
| Q4 2024 · Jun 30derived | — | — | — | −$9.7M | −$6.5M | — | -0.39 | −$3.6M | $3K | −$3.6M | Sep 29 |
| Q3 2024 · Mar 31 | — | — | — | −$7.4M | −$6M | — | -0.38 | −$4.4M | −$6K | −$4.3M | May 15 |
| Q2 2024 · Dec 31 | — | — | — | −$8M | −$5.2M | — | -0.33 | −$2.1M | $59K | −$2.2M | Feb 14 |
| Q1 2024 · Sep 30 | — | — | — | −$4.9M | −$726K | — | -0.08 | −$5.7M | $221K | −$6M | Nov 14 |
| Q4 2023 · Jun 30derived | — | — | — | −$4.2M | −$4.2M | — | -0.39 | −$2.6M | $171K | −$2.8M | Sep 30 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Jun 30 | — | — | −$23.8M | −$46.9M | — | -1.35 | −$12.5M | $8K | −$12.5M | — | — |
| FY2024 · to Jun 30 | $12K | — | −$30M | −$18.5M | -153825.0% | -1.15 | −$15.8M | $277K | −$16.1M | — | — |
| FY2024 · to Dec 31 | — | — | — | — | — | 0.38 | — | — | — | — | — |
| FY2023 · to Jun 30 | — | — | −$49.7M | −$48.8M | — | -3.32 | −$10.7M | $316K | −$11.1M | — | — |
| FY2023 · to Dec 31 | — | — | — | — | — | 2.76 | — | — | — | — | — |
Every number comes from Incannex Healthcare Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.